SCHEMBL61011

SCHEMBL61011

CCC1(c2ccccc2)C=CC=CC1C1CCCCC1

nearest known ligand 0.35

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 3/20 0.35
SLC6A4 P31645 3/20 0.35
SLC18A3 Q16572 1/20 0.34
CHRM2 P08172 4/20 0.33
CHRM4 P08173 4/20 0.33
CHRM5 P08912 4/20 0.33
CHRM1 P11229 4/20 0.33
CHRM3 P20309 4/20 0.33
OPRM1 P35372 1/20 0.32
GRIN1 Q05586 1/20 0.32
GRIN2A Q12879 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10640090 0.73 MEN1 (0.31)
SCHEMBL9064776 0.72 MEN1 (0.30)
SCHEMBL29033525 0.71 KDM1A (0.34)
SCHEMBL1784471 0.71 TSHR (0.33)
SCHEMBL10602846 0.70
SCHEMBL8776943 0.70 CYP2D6 (0.30)
SCHEMBL6548185 0.65 KDM1A (0.33)
SCHEMBL11146285 0.65
SCHEMBL27544510 0.65 NPC1 (0.34) SLC18A3
SCHEMBL10640077 0.64 KDM1A (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 897 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11814563-B2 Bioreachable chiral dopants for liquid crystal applications ZYMERGEN INC. (US) 2023-11-14 US claimed
US-20230203378-A1 FORMULATIONS OF BIOREACHABLE DOPANTS FOR LIQUID CRYSTALS KENT STATE UNIVERSITY 2023-06-29 US claimed
US-20220025267-A1 BIOREACHABLE CHIRAL DOPANTS FOR LIQUID CRYSTAL APPLICATIONS ZYMERGEN ACQUISITION SUB, INC. 2022-01-27 US claimed
CN-113454187-A Biologically available chiral dopants for liquid crystal applications 齐默尔根公司 2021-09-28 CN claimed
CN-1201182-C Liquid crystal display contg. chiral dopant MERCK PATENT GMBH (DE) 2005-05-11 CN claimed
US-6602562-B2 High dielectric anisotropy and clearing point with little impact on voltage holding ratio, low temperature stability and response time MERCK PATENT GESELLSCHAFT MIT (DE) 2003-08-05 US claimed
US-20030113482-A1 Realignment layer; field has a component parallel to the liquid-crystal layer; positive dielectric anisotropy MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2003-06-19 US claimed
CN-1420382-A Liquid crystal display contg. chiral dopant MERCK PATENT GMBH (DE) 2003-05-28 CN claimed
US-6217792-B1 Chiral dopants MERCK PATENT GMBH (DE) 2001-04-17 US claimed
EP-0408995-B1 Liquid crystal medium with limited temperature-dependence of the d/p coefficient MERCK PATENT GMBH (DE) 1995-11-08 EP claimed
US-5139698-A Achiral liquid crystal compound with doping component MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1992-08-18 US claimed
EP-0408995-A2 Liquid crystal medium with limited temperature-dependence of the d/p coefficient MERCK PATENT GmbH (DE) 1991-01-23 EP claimed
EP-4294890-B1 LIQUID-CRYSTALLINE COMPOUNDS MERCK PATENT GMBH (DE) 2025-10-22 EP disclosed
CN-115087718-B Liquid crystal compound 默克专利股份有限公司 2024-12-13 CN disclosed
CN-111170984-B Liquid crystal compound 默克专利股份有限公司 2024-09-10 CN disclosed
CN-110997871-B Liquid crystal compound 默克专利股份有限公司 2024-04-30 CN disclosed
WO-1989008687-A1 2,3-DIFLUOROBIPHENYLS MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1989-09-21 WO disclosed
WO-1989008637-A1 DERIVATIVES OF 2,3-DIFLUOROHYDROQUINONE MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1989-09-21 WO disclosed
EP-0332024-A1 Heterocyclic derivatives of 1,2-difluorobenzene MERCK PATENT GmbH (DE) 1989-09-13 EP disclosed
EP-0332007-A1 Derivatives of 2,3-difluorohydroquinone MERCK PATENT GmbH (DE) 1989-09-13 EP disclosed